Texas Register

TITLE 22 EXAMINING BOARDS
PART 9TEXAS MEDICAL BOARD
CHAPTER 190DISCIPLINARY GUIDELINES
SUBCHAPTER BVIOLATION GUIDELINES
RULE §190.8Violation Guidelines
ISSUE 04/01/2016
ACTION Proposed
Preamble Texas Admin Code Rule

When substantiated by credible evidence, the following acts, practices, and conduct are considered to be violations of the Act. The following shall not be considered an exhaustive or exclusive listing.

  (1)Practice Inconsistent with Public Health and Welfare. Failure to practice in an acceptable professional manner consistent with public health and welfare within the meaning of the Act includes, but is not limited to:

    (A)failure to treat a patient according to the generally accepted standard of care;

    (B)negligence in performing medical services;

    (C)failure to use proper diligence in one's professional practice;

    (D)failure to safeguard against potential complications;

    (E)improper utilization review;

    (F)failure to timely respond in person when on-call or when requested by emergency room or hospital staff;

    (G)failure to disclose reasonably foreseeable side effects of a procedure or treatment;

    (H)failure to disclose reasonable alternative treatments to a proposed procedure or treatment;

    (I)failure to obtain informed consent from the patient or other person authorized by law to consent to treatment on the patient's behalf before performing tests, treatments, procedures, or autopsies as required under Chapter 49 of the Code of Criminal Procedure;

    (J)termination of patient care without providing reasonable notice to the patient;

    (K)prescription or administration of a drug in a manner that is not in compliance with Chapter 200 of this title (relating to Standards for Physicians Practicing Complementary and Alternative Medicine) or, that is either not approved by the Food and Drug Administration (FDA) for use in human beings or does not meet standards for off-label use, unless an exemption has otherwise been obtained from the FDA;

    (L)prescription of any dangerous drug or controlled substance without first establishing a defined physician-patient relationship.

      (i)A defined physician-patient relationship must include, at a minimum:

        (I)establishing that the person requesting the medication is in fact who the person claims to be;

        (II) establishing a diagnosis through the use of acceptable medical practices, which includes documenting and performing:

          (-a-)patient history;

          (-b-)mental status examination;

          (-c-)physical examination that must be performed by either a face-to-face visit or in-person evaluation as defined in §174.2(3) and (4) of this title (relating to Definitions). The requirement for a face-to-face or in-person evaluation does not apply to mental health services, except in cases of behavioral emergencies, as defined by 25 TAC §415.253 (relating to Definitions); and

          (-d-)appropriate diagnostic and laboratory testing.

        (III)An online questionnaire or questions and answers exchanged through email, electronic text, or chat or telephonic evaluation of or consultation with a patient are inadequate to establish a defined physician-patient relationship;

        (IV)discussing with the patient the diagnosis and the evidence for it, the risks and benefits of various treatment options; and

        (V)ensuring the availability of the licensee or coverage of the patient for appropriate follow-up care.

      (ii)A proper professional relationship is also considered to exist between a patient certified as having a terminal illness and who is enrolled in a hospice program, or another similar formal program which meets the requirements of subclauses (I) through (IV) of this clause, and the physician supporting the program. To have a terminal condition for the purposes of this rule, the patient must be certified as having a terminal illness under the requirements of 40 TAC §97.403 (relating to Standards Specific to Agencies Licensed to Provide Hospice Service) and 42 CFR 418.22.

      (iii)Notwithstanding the provisions of this subparagraph, establishing a professional relationship is not required for:

        (I)a physician to prescribe medications for sexually transmitted diseases for partners of the physician's established patient, if the physician determines that the patient may have been infected with a sexually transmitted disease; or

        (II)a physician to prescribe dangerous drugs and/or vaccines for post-exposure prophylaxis of disease for close contacts of a patient [a patient's close contacts] if the physician diagnoses the patient with one or more of the following infectious diseases listed in items (-a-) - (-g-) of this subclause, or is providing public health medical services pursuant to a memorandum of understanding entered into between the board and the Department of State Health Services. For the purpose of this clause, a "close contact" is defined as a member of the patient's household or any person with significant exposure to the patient for whom post-exposure prophylaxis is recommended by the Centers for Disease Control and Prevention, Texas Department of State Health Services, or local health department or authority ("local health authority or department" as defined under Chapter 81 of the Texas Health and Safety Code).[ : any person who provided care for the patient while the patient was symptomatic; or a member of the patient's household.] The physician must document the treatment provided to the patient's close contact(s) in the patient's medical record. Such documentation at a minimum must include the close contact's name, drug prescribed, and the date that the prescription was provided.

           [(-a-)Chicken Pox;]

          (-a-)[(b)] Influenza;

          (-b-)[(c)] Invasive Haemophilus influenzae Type B;

          (-c-)[(d)] Meningococcal disease;

          (-d-)[(e)] Pertussis;

          (-e-)[(f)] Scabies; [or]

          (-f-)[(g)] Varicella zoster; or [Shingles.]

           (-g-)a communicable disease determined by the Texas Department of State Health Services to:

            (-1-)present an immediate threat of a high risk of death or serious long-term disability to a large number of people; and

            (-2-)create a substantial risk of public exposure because of the disease's high level of contagion or the method by which the disease is transmitted.

    (M) - (O)(No change.)

  (2) - (8)(No change.)

The agency certifies that legal counsel has reviewed the proposal and found it to be within the state agency's legal authority to adopt.

Filed with the Office of the Secretary of State on March 18, 2016

TRD-201601300

Mari Robinson, J.D.

Executive Director

Texas Medical Board

Earliest possible date of adoption: May 1, 2016

For further information, please call: (512) 305-7016



Next Page Previous Page

Link to Texas Secretary of State Home Page | link to Texas Register home page | link to Texas Administrative Code home page | link to Open Meetings home page